相关实验视频

Updated: May 10, 2026

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection
10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

11.2K

肝脏非帕伦基马细胞在使用基于 perfluoropolyether 的微流体装置时,对药物诱导的肝细胞毒性的保护作用

Mengyang Wang1, Qiyue Zhang1, Kazuma Aoki2

  • 1Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto 606-8501, Japan.

Toxicology letters
|March 21, 2025
PubMed
概括

肝脏非帕伦基马细胞 (NPC) 通过分泌IL-6 (IL-6) 来保护初级肝细胞免受药物毒性影响. 这项研究强调了NPC.

关键词:
药物诱导的肝损伤是药物诱导的肝脏的非辅酶细胞.微流体设备的使用方法通过化聚乙烯.主要肝细胞主要是肝细胞.

更多相关视频

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

6.6K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...